698 filings
Page 3 of 35
8-K
fvs vnjs2n7e
1 Nov 22
Acorda Therapeutics Reports Third Quarter 2022 Financial Results
4:10pm
DEFA14A
198y5bqx7rvgk2pz08
31 Oct 22
Additional proxy soliciting materials
5:00pm
DEFA14A
lk725r
31 Oct 22
Additional proxy soliciting materials
6:05am
DEFA14A
r8el0heienf 3tmzh
28 Oct 22
Additional proxy soliciting materials
9:37am
8-K/A
vjpwfl lpdcja
28 Oct 22
Other Events
9:37am
DEFA14A
60r1vpe98ptpymk7b1ba
27 Oct 22
Additional proxy soliciting materials
7:19am
8-K
4i4j9nvg79f
27 Oct 22
Other Events
7:17am
DEFA14A
n54 k2bn2s
26 Oct 22
Additional proxy soliciting materials
5:02pm
DEFA14A
0ql0oqe90r3klqov08
25 Oct 22
Additional proxy soliciting materials
5:00pm
DEFA14A
8dvvdn0xok tpr
24 Oct 22
Additional proxy soliciting materials
9:51pm
DEFA14A
rjvoodj
24 Oct 22
Additional proxy soliciting materials
9:49pm
DEFA14A
slshx9
21 Oct 22
Additional proxy soliciting materials
9:34pm
DEFA14A
z7aixtzgsyn9x3ok4i
21 Oct 22
Additional proxy soliciting materials
4:10pm
DEFA14A
dpkgb22 zf2r
19 Oct 22
Additional proxy soliciting materials
4:11pm
DEFA14A
pz2ojrhrmtayisu
19 Oct 22
Additional proxy soliciting materials
4:10pm
DEFA14A
sbucz6ll4z9htg vpnf
19 Oct 22
Additional proxy soliciting materials
4:07pm
8-K
3qxxuyd1
19 Oct 22
ISS, Glass Lewis and Egan-Jones Recommend that Acorda Stockholders Vote FOR the Proposal to Implement a Reverse Stock Split
4:05pm
8-K
vnwal0wr b6hkdvmvw8
18 Oct 22
Other Events
1:00pm
8-K
lcv v4mjbzzgza7y
17 Oct 22
Acorda Therapeutics Announces $16.5M Award and Royalty/Supply Relief in AMPYRA® Arbitration Case
9:00am
DEFA14A
kp73khbfk1
11 Oct 22
Additional proxy soliciting materials
4:18pm